Community acquired paediatric pneumonia; experience from a pneumococcal vaccine- naive population
- PDF / 802,676 Bytes
- 7 Pages / 595.276 x 790.866 pts Page_size
- 13 Downloads / 184 Views
Pneumonia
RESEARCH
Open Access
Community acquired paediatric pneumonia; experience from a pneumococcal vaccine- naive population Sanath Thushara Kudagammana1* , Ruchira Ruwanthika Karunaratne1, Thilini Surenika Munasinghe1 and Haputhanthirige Donna Wasana Samankumari Kudagammana2
Abstract Background: Childhood pneumonia continues to be a disease that causes severe morbidity and mortality among children mainly in South-East Asia and Africa though it is not so in the developed world. Pneumonia accounts for 16% of all deaths of children under 5 years old in the world, killing nearly one million children in 2015. In Sri Lanka, there were 21,000 reported cases of pneumonia in 2006, 40% were in the age group of less than 4 years. Methods: This was a retrospective study done on the children aged 1 month to 14 years who were admitted to the Professorial Paediatric unit of Teaching Hospital, Peradeniya between 1st of March 2016 and 30th of July 2017 fulfilling diagnostic criteria for community-acquired pneumonia. Data including diagnosis, clinical details, management details and other relevant data were collected from patient records by using a data collection sheet. Results: In this study, 48% of 127 patients admitted with community-acquired pneumonia had bronchopneumonia. About 2/3 of the patients neededa secondline of intravenous antibiotics while 51/ 127 needed care in the high dependency unit with supplemental oxygen. No mortality was observed in the group. Conclusions: Community- acquired paediatric pneumonia has a significant associated morbidity but not mortality in the studied population. The need for the second-line treatment with intravenous antibiotics in a significant proportion of patients may indicate a high degree of antibiotic resistance. Introduction of national antibiotic policy will help the cause. Keywords: Community acquired pneumonia, Paediatric pneumonia, Pneumococcal pneumonia
Background Childhood pneumonia continues to be a disease that causes severe morbidity and mortality among children mainly in South-East Asia and Africa though it is not so in the developed world. Pneumonia accounts for 16% of all deaths of children under 5 years old in the world, killing nearly one million children in 2015. In Sri Lanka, there were 21,000 reported cases of pneumonia in 2006, 40% were in the age group of less than 4 years [1]. * Correspondence: [email protected] 1 Department of Paediatrics, Faculty of Medicine, University of Peradeniya, Peradeniya 20400, Sri Lanka Full list of author information is available at the end of the article
Pneumonia is defined as inflammation of the lung parenchyma due to infection leading to consolidation of pulmonary tissue. When pneumonia is acquired in the community by a previously well person it is defined as community-acquired pneumonia [2]. Pneumonia can also be categorised as bronchopneumonia and lobar pneumonia according to the pathophysiological basis [3] and viral, bacterial, fungal or tuberculous pneumonia on an aetiological basis [4]. Atypical pneumonia is caus
Data Loading...
